Formal indication to oral anticoagulation beside atrial fibrillation (mechanic heart valves, recurrent thrombophlebitis, antiphospholipid syndrome)
Life expectancy < 6 months (e.g., terminal cancer)
Live donor transplantation scheduled within 6 months
Pregnancy (ß-HCG blood-based assay)or nursing (lactating) women
Women of child bearing potential, unless they are using an effective method of birth control
Patient under legal guardianship
Patients under law protection
Known hypersensibility to coumadin or indoine derivatives or to any excipients (CI to oral AVK)
Severe liver failure (CI to oral AVK)

NCT02886962_exc_T1
Condition
indication
NCT02886962_exc_T2
Drug
oral anticoagulation
NCT02886962_exc_T3
Condition
atrial fibrillation
NCT02886962_exc_T4
Device
mechanic heart valves
NCT02886962_exc_T5
Condition
recurrent thrombophlebitis
NCT02886962_exc_T6
Condition
antiphospholipid syndrome
NCT02886962_exc_T7
Scope
mechanic heart valves, recurrent thrombophlebitis, antiphospholipid syndrome
NCT02886962_exc_T8
Observation
Life expectancy
NCT02886962_exc_T9
Value
< 6 months
NCT02886962_exc_T10
Condition
terminal cancer
NCT02886962_exc_T11
Procedure
Live donor transplantation
NCT02886962_exc_T12
Temporal
within 6 months
NCT02886962_exc_T13
Mood
scheduled
NCT02886962_exc_T18
Condition
hypersensibility
NCT02886962_exc_T19
Drug
coumadin
NCT02886962_exc_T20
Drug
indoine
NCT02886962_exc_T21
Scope
coumadin or indoine
NCT02886962_exc_T22
Condition
liver failure
NCT02886962_exc_T23
Qualifier
Severe